The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050

January 25, 2005 |

British Journal of Cancer. (2005) 92, 587-593. doi:10.1038/sj.bjc.6602307 Published online 25 January 2005. [Link] J T Hodgson1, D M McElvenny1, A J Darnton1, M J Price1 and J Peto2,3 1Epidemiology…

Radiofrequency Ablation of Thoracic Lesions: Part 2, Initial Clinical Experience Technical and Multidisciplinary Considerations in 30 Patients

January 25, 2005 |

American Journal of Roentgenology 184, no 2 (2005): 381-390. [Link] Eric vanSonnenberg1,2, Sridhar Shankar1,2,3, Paul R. Morrison1, Rashmi T. Nair1,2, Stuart G. Silverman1,2, Michael T. Jaklitsch4,5, Franklin Liu1,2,6, Lawrence Cheung1,2,…

Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients

January 24, 2005 |

Lung Cancer. 2005 Jun;48(3):429-34. Epub 2005 Jan 24. [Link] Porta C, Zimatore M, Bonomi L, Imarisio I, Paglino C, Sartore-Bianchi A, Mutti L. Medical Oncology, I.R.C.C.S. San Matteo University Hospital,…

The Effects of Taurolidine, a Novel Antineoplastic Agent, on Human Malignant Mesothelioma

November 15, 2004 |

Clinical Cancer Research Vol. 10, 7655-7661, November 15, 2004 [Link] Linda Nici, Barbara Monfils and Paul Calabresi Department of Medicine, Rhode Island Hospital and Brown University, Providence, Rhode Island Abstract…

Patterns of failure following surgical resection for malignant pleural mesothelioma

November 1, 2004 | Comments Off on Patterns of failure following surgical resection for malignant pleural mesothelioma

Thoracic Surgery Clinics. 2004 Nov;14(4):567-73. [Link] Janne PA, Baldini EH Harvard Medical School, Boston, MA 02115, USA. pjanne@partners.org Abstract The optimum therapeutic strategy for patients with localized malignant mesothelioma continues…

Intrapleural Staphylococcal Superantigen Induces Resolution of Malignant Pleural Effusions and a Survival Benefit in Non-Small Cell Lung Cancer

November 1, 2004 |

Chest, no. 126 (2004): 1529-1539. [Link] Shaohua Ren, MD; David S. Terman, MD; Greg Bohach, PhD; Abraham Silvers, PhD; Chris Hansen, MD; Henri Colt, MD, FCCP and Steven A. Sahn,…

Pleural mesothelioma: little evidence, still time to do trials

September 25, 2004 |

The Lancet 364, no. 9440 (2004): 1183-5. [Link] Treasure T, Sedrakyan A. Cardiothoracic Unit, Guy’s Hospital, London SE1 9RT, UK. Tom.Treasure@ukgateway.net Abstract Context: The incidence of malignant pleural mesothelioma is…

Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PC

September 25, 2004 |

The Lancet 364, no. 9440 (2004): 1157-66. [Link] Lopez-Rios F, Illei PB, Rusch V, Ladanyi M. Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021,…

Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma

August 24, 2004 |

The Annals of Thoracic Surgery. Volume 78, Issue 3 , September 2004, Pages 1042-1051. (Available online 26 August 2004.) [Link] Robert E. Merritt MDa, Reiko E. Yamada BAa, Nabil Wasif…

Pemetrexed in combination with cisplatin in the treatment of chemonaive patients with malignant pleural mesothelioma (MPM): Outcomes on Expanded Access Program (EAP).

July 15, 2004 |

Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14S (July 15 Supplement), 2004: 7192. Link A. J. Wozniak, P. Janne, C. P. Belani, M.…

Categories